期刊文献+

生长因子在组织工程气管临床移植中的应用与展望

Application and prospect of growth factors in clinical transplantation of tissue engineering trachea
原文传递
导出
摘要 组织工程技术为气管重建外科提供了有效治疗手段,而如何实现移植气管的上皮细胞再生、软骨细胞再生以及血管新生是维持气道功能、保障气管移植物长期存活的关键所在。生长因子是一类通过对细胞的增殖、迁移、分化提供生物化学诱导从而指导细胞发展的信号分子,在组织工程气管再生过程中扮演着重要角色。如何设计一种能够为生长因子提供最佳活性、稳定性和可调节性的呈递系统尤为重要。本研究旨在综述应用于组织工程气管领域的生长因子的类型、特征、功能以及生长因子在组织工程气管体内原位移植中应用价值,以促进组织工程气管原位移植早日实现临床转化。 Tissue engineering provides an effective treatment for tracheal reconstruction.The key to maintain airway function and ensure long-term survival of tracheal grafts is how to achieve epithelial cell regeneration,chondrocyte regeneration,and angiogenesis of the transplanted trachea.Growth factors are signaling molecules that direct cell development by providing biochemical cues for stem cell proliferation,migration,and differentiation.They play an important role in tissue engineering trachea regeneration.It is particularly important to design a delivery system that provides optimal activity,stability and adjustability for growth factors.This article summarizes the types,characteristics,functions of growth factors applied in the field of tissue engineering trachea,and the value of gr nwth factors in tissue engineering trachea orthotopic transplantation aimed for promoting clinical transformation of tissue engineered trachea.
作者 孙飞 王志豪 史宏灿 Sun Fei;Wang Zhihao;Shi Hongcan(Department of Thoracic Surgery,Clinical Medical College,Yangzhou Universityy Yangzhou 225001,China)
出处 《国际外科学杂志》 2020年第7期493-496,共4页 International Journal of Surgery
基金 国家自然科学基金(81770018)。
关键词 组织工程 气管 再生医学 临床移植 生长因子 Tissue engineering Trachea Regenerative medicine Clinical transplantation Growth factor
  • 相关文献

参考文献1

二级参考文献52

  • 1Marks SC, Hermey DC. The structure and development of bone. In: Bilezekian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press; 1996: 3-24.
  • 2Kanczler JM, Oreffo RO. Osteogenesis and angiogenesis: the potential for engineering bone. EurCell Mater2008; 2(15): 100-114.
  • 3Mandracchia V J, Nelson SC, Barp EA. Current concepts of bone healing. Clin Podiatr MedSurg2001; 18(1): 55-77.
  • 4Rabie AB. Vascular endothelial growth pattern during demineralized bone matrix induced osteogenesis. Connect Tissue Res 1997; 36(4): 337-345.
  • 5Carmeliet P, Ferreira V, Breier Get al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380(6573): 435- 439.
  • 6Ferrara N, Carver-Moore K, Chen H etal. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380(6573): 439-443.
  • 7Gerber HP, Hillan K J, Ryan AM et al. VEGF is required for growth and survival in neonatal mice. Development 1999; 126(6): 1149-1159.
  • 8Emad B, Sherif EM, Basma GM etal. Vascular endothelial growth factor augments the healing of demineralized bone matrix grafts. Int J Sure 2006; 4(3): 160-166.
  • 9Dai J, Rabie AB. Direct AAV-mediated gene delivery to the temporomandibular joint. Front Biosci 2007; 12:2212-2220.
  • 10Dai J, Rabie AB. Recombinant adeno-associated virus vector hybrids efficiently target different skeletal cells. Front Biosci2007; 12: 4280-4287.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部